OOIR: Observatory of International Research

Papers

(The H4-Index of American Journal of Psychiatry is 49. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation	346
Stanford Neuromodulation Therapy (SNT): A Double-Blind Randomized Controlled Trial	307
Improving Suicide Prevention Through Evidence-Based Strategies: A Systematic Review	257
From Womb to Neighborhood: A Racial Analysis of Social Determinants of Psychosis in the United States	143
A Randomized Controlled Trial of Repeated Ketamine Administration for Chronic Posttraumatic Stress Disorder	143
Neuroimaging Biomarkers in Schizophrenia	137
Variable Patterns of Remission From ADHD in the Multimodal Treatment Study of ADHD	137
Elevated C-Reactive Protein in Patients With Depression, Independent of Genetic, Health, and Psychosocial Factors: Results From the UK Biobank	126
The Overlapping Neurobiology of Induced and Pathological Anxiety: A Meta-Analysis of Functional Neural Activation	117
Addiction as a Coping Response: Hyperkatifeia, Deaths of Despair, and COVID-19	109
Harmonizing the Neurobiology and Treatment of Obsessive-Compulsive Disorder	105
Association of Prenatal Alcohol Exposure With Psychological, Behavioral, and Neurodevelopmental Outcomes in Children From the Adolescent Brain Cognitive Development Study	99
Anticholinergic Medication Burden–Associated Cognitive Impairment in Schizophrenia	99
Dismantling Structural Racism in Psychiatry: A Path to Mental Health Equity	98
Association Between Systemic Inflammation and Individual Symptoms of Depression: A Pooled Analysis of 15 Population-Based Cohort Studies	92
Psychotherapy at a Distance	85
The Impact of COVID-19 on Individuals With Intellectual and Developmental Disabilities: Clinical and Scientific Priorities	77
Effects of Olanzapine Combined With Samidorphan on Weight Gain in Schizophrenia: A 24-Week Phase 3 Study	76
Autism Spectrum Disorder Genetics and the Search for Pathological Mechanisms	74
Efficacy of Intravenous Ketamine in Adolescent Treatment-Resistant Depression: A Randomized Midazolam-Controlled Trial	73
Defining Recovery From Alcohol Use Disorder: Development of an NIAAA Research Definition	72
Adjunctive Ketamine With Relapse Prevention–Based Psychological Therapy in the Treatment of Alcohol Use Disorder	67
Toward a Better Understanding of the Mechanisms and Pathophysiology of Anhedonia: Are We Ready for Translation?	67
Early Adversity and Development: Parsing Heterogeneity and Identifying Pathways of Risk and Resilience	66
A Genetics-First Approach to Dissecting the Heterogeneity of Autism: Phenotypic Comparison of Autism Risk Copy Number Variants	66

Effect of AXS-05 (Dextromethorphan-Bupropion) in Major Depressive Disorder: A Randomized Double-Blind Controlled Trial	65
Large-Scale Functional Brain Network Architecture Changes Associated With Trauma-Related Dissociation	65
Zuranolone for the Treatment of Postpartum Depression	64
Item-Level Genome-Wide Association Study of the Alcohol Use Disorders Identification Test in Three Population-Based Cohorts	63
Disparities in Screening and Treatment of Cardiovascular Diseases in Patients With Mental Disorders Across the World: Systematic Review and Meta-Analysis of 47 Observational Studies	63
Efficacy and Safety of Lumateperone for Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder: A Phase 3 Randomized Placebo-Controlled Trial	63
The Evolving Nexus of Sleep and Depression	61
The American Psychiatric Association Practice Guideline for the Treatment of Patients With Eating Disorders	60
Childhood Maltreatment and Mental Health Problems: A Systematic Review and Meta-Analysis of Quasi-Experimental Studies	58
Sleep Abnormalities in Schizophrenia: State of the Art and Next Steps	57
Maintenance Treatment With Long-Acting Injectable Antipsychotics for People With Nonaffective Psychoses: A Network Meta-Analysis	57
Incident Major Depressive Disorder Predicted by Three Measures of Insulin Resistance: A Dutch Cohort Study	57
Alcohol, Tobacco, and Comorbid Psychiatric Disorders and Associations With Sexual Identity and Stress-Related Correlates	56
Disrupted Dorsal Mid-Insula Activation During Interoception Across Psychiatric Disorders	55
Effect Sizes of Deletions and Duplications on Autism Risk Across the Genome	53
The Intergenerational Impact of Structural Racism and Cumulative Trauma on Depression	53
Structural Racism and Suicide Prevention for Ethnoracially Minoritized Youth: A Conceptual Framework and Illustration Across Systems	52
REL-1017 (Esmethadone) as Adjunctive Treatment in Patients With Major Depressive Disorder: A Phase 2a Randomized Double-Blind Trial	52
Pervasively Thinner Neocortex as a Transdiagnostic Feature of General Psychopathology	52
Charting the Landscape of Genetic Overlap Between Mental Disorders and Related Traits Beyond Genetic Correlation	51
Antibodies From Children With PANDAS Bind Specifically to Striatal Cholinergic Interneurons and Alter Their Activity	51
Functional Connectome Prediction of Anxiety Related to the COVID-19 Pandemic	49
Subjective Responses to Alcohol in the Development and Maintenance of Alcohol Use Disorder	49
Fifty Years of Research on Schizophrenia: The Ascendance of the Glutamatergic Synapse	49